Search
for
Sort by
Research 31–60 of 1000+
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- NEW YORK DERMATOLOGICAL SOCIETY
- Dermatological drugs, topical agents, and cosmetics
- An Update on Drug-Induced Pigmentation
- Spontaneous cutaneous adverse drug reaction reports—An analysis of a 10‐year dataset in Singapore
- Acneiform Rash Caused by an Unlikely Drug: Topiramate
- Acne and acneiform eruptions
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases
- Cutaneous signs in COVID ‐19 patients: A review
- Dermatological adverse events with taxane chemotherapy
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- Anatomical view of administration route of Murdha Taila
- Prevalence and Clinical Spectrum of Dermatologic Conditions in Renal Transplant Recipients: A 10-Year Retrospective Cross-Sectional Study
- Telogen Effluvium
- Telogen Effluvium Caused by Magnesium Valproate and Lamotrigine
- Cutaneous manifestations of the COVID-19 pandemic in schoolchildren and adolescents
- Adverse Cutaneous Reactions to Mood Stabilizers
- RASopathic Skin Eruptions during Vemurafenib Therapy
- Cutaneous Adverse Drug Reactions to Antibiotics: How Much is the Extent of the Problem?
- Nanocarrier Systems for Transdermal Drug Delivery
- Suspected upadacitinib-associated drug hypersensitivity mimicking disease exacerbation in ulcerative colitis
- Drug-induced hair pigmentation: Clinical perspectives and updates
- Hair Changes due to Drugs
- Perspective Chapter: Appraisal of Paclitaxel (Taxol) Pros and Cons in the Management of Cancer – Prospects in Drug Repurposing
- Fatal Case of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Induced by Doxycycline or Flucloxacillin in a 77-Year-Old Woman: A Rare but Serious Adverse Drug Reaction
- Poster Abstracts
- Mucocutaneous reactions to chemotherapy
- Anticonvulsant-Induced Cutaneous Reactions
- Sodium Valproate-Induced Hyperpigmentation
- Cutaneous manifestations associated with substance use disorders